vs
Side-by-side financial comparison of Goosehead Insurance, Inc. (GSHD) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
Goosehead Insurance, Inc. is the larger business by last-quarter revenue ($93.1M vs $83.1M, roughly 1.1× PROCEPT BioRobotics Corp). Goosehead Insurance, Inc. runs the higher net margin — 8.6% vs -38.1%, a 46.7% gap on every dollar of revenue. On growth, Goosehead Insurance, Inc. posted the faster year-over-year revenue change (23.1% vs 20.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 9.2%).
Goosehead Insurance is a U.S.-based personal lines insurance agency that offers a wide range of coverage products including auto, home, renters, flood, and specialty insurance. It partners with hundreds of insurance carriers to provide clients with tailored, cost-effective coverage options, operating via corporate locations and a national franchise network for independent agents.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
GSHD vs PRCT — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $93.1M | $83.1M |
| Net Profit | $8.0M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | 16.1% | -4.1% |
| Net Margin | 8.6% | -38.1% |
| Revenue YoY | 23.1% | 20.2% |
| Net Profit YoY | 204.0% | -27.9% |
| EPS (diluted) | $0.19 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $93.1M | $83.1M | ||
| Q4 25 | $105.3M | $76.4M | ||
| Q3 25 | $90.4M | $83.3M | ||
| Q2 25 | $94.0M | $79.2M | ||
| Q1 25 | $75.6M | $69.2M | ||
| Q4 24 | $93.9M | $68.2M | ||
| Q3 24 | $78.0M | $58.4M | ||
| Q2 24 | $78.1M | $53.4M |
| Q1 26 | $8.0M | $-31.6M | ||
| Q4 25 | $12.4M | $-29.8M | ||
| Q3 25 | $7.9M | $-21.4M | ||
| Q2 25 | $5.2M | $-19.6M | ||
| Q1 25 | $2.3M | $-24.7M | ||
| Q4 24 | $14.9M | $-18.9M | ||
| Q3 24 | $7.6M | $-21.0M | ||
| Q2 24 | $6.2M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | 16.1% | -4.1% | ||
| Q4 25 | 29.4% | -40.6% | ||
| Q3 25 | 23.5% | -27.8% | ||
| Q2 25 | 16.7% | -28.0% | ||
| Q1 25 | 8.8% | -39.7% | ||
| Q4 24 | 29.7% | -28.9% | ||
| Q3 24 | 21.1% | -38.4% | ||
| Q2 24 | 19.7% | -50.3% |
| Q1 26 | 8.6% | -38.1% | ||
| Q4 25 | 11.8% | -39.1% | ||
| Q3 25 | 8.7% | -25.7% | ||
| Q2 25 | 5.5% | -24.7% | ||
| Q1 25 | 3.1% | -35.8% | ||
| Q4 24 | 15.8% | -27.6% | ||
| Q3 24 | 9.7% | -35.9% | ||
| Q2 24 | 7.9% | -48.0% |
| Q1 26 | $0.19 | $-0.56 | ||
| Q4 25 | $0.48 | $-0.54 | ||
| Q3 25 | $0.29 | $-0.38 | ||
| Q2 25 | $0.18 | $-0.35 | ||
| Q1 25 | $0.09 | $-0.45 | ||
| Q4 24 | $0.58 | $-0.34 | ||
| Q3 24 | $0.29 | $-0.40 | ||
| Q2 24 | $0.24 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $25.7M | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | $-121.3M | $347.7M |
| Total Assets | $392.8M | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $25.7M | $245.6M | ||
| Q4 25 | $34.4M | $286.5M | ||
| Q3 25 | $51.6M | $294.3M | ||
| Q2 25 | $92.4M | $302.7M | ||
| Q1 25 | $70.2M | $316.2M | ||
| Q4 24 | $54.3M | $333.7M | ||
| Q3 24 | $47.5M | $196.8M | ||
| Q2 24 | $23.6M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | $289.5M | $51.6M | ||
| Q3 25 | $290.0M | $51.6M | ||
| Q2 25 | $289.8M | $51.5M | ||
| Q1 25 | $290.3M | $51.5M | ||
| Q4 24 | $82.3M | $51.5M | ||
| Q3 24 | $84.6M | $51.4M | ||
| Q2 24 | $87.0M | $51.4M |
| Q1 26 | $-121.3M | $347.7M | ||
| Q4 25 | $-95.5M | $365.9M | ||
| Q3 25 | $-105.0M | $380.3M | ||
| Q2 25 | $-78.6M | $385.8M | ||
| Q1 25 | $-88.5M | $389.2M | ||
| Q4 24 | $43.9M | $402.2M | ||
| Q3 24 | $58.3M | $241.2M | ||
| Q2 24 | $39.8M | $251.8M |
| Q1 26 | $392.8M | $487.1M | ||
| Q4 25 | $414.9M | $508.1M | ||
| Q3 25 | $403.6M | $511.5M | ||
| Q2 25 | $436.6M | $513.1M | ||
| Q1 25 | $412.6M | $519.4M | ||
| Q4 24 | $397.7M | $534.0M | ||
| Q3 24 | $358.1M | $374.1M | ||
| Q2 24 | $338.2M | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | 1.87× | 0.13× | ||
| Q3 24 | 1.45× | 0.21× | ||
| Q2 24 | 2.19× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GSHD
| Renewal Royalty Fees (2) | $43.6M | 47% |
| Renewal Commissions (1) | $18.2M | 20% |
| Contingent Commissions (1) | $10.7M | 11% |
| New Business Royalty Fees (2) | $7.9M | 8% |
| New Business Commissions (1) | $7.5M | 8% |
| Other | $3.7M | 4% |
| Initial Franchise Fees (2) | $1.6M | 2% |
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
